SCHEMBL13844902

SCHEMBL13844902

Nc1ccc(S(=O)(=O)N2CCC(C(=O)c3c[nH]c4ccccc34)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.55
HTR3B O95264 3/20 0.55
HTR3A P46098 3/20 0.55
HTR3D Q70Z44 3/20 0.55
HTR3C Q8WXA8 3/20 0.55
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.49
F2 P00734 1/20 0.47
PRSS1 P07477 1/20 0.47
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 2/20 0.43
PKM P14618 1/20 0.43
TP53 P04637 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17025733 0.77 HTR3E (0.82) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL3301477 0.75 IKBKB (0.47) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2078783 0.74 HTR3E (0.78) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2079279 0.73 HTR3E (0.76) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1019079 0.71 MEN1 (0.60) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL16913002 0.71 MEN1 (0.60) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL13844901 0.71 ALDH1A1 (0.77) KMT2AMEN1ALDH1A1GAA
SCHEMBL18324710 0.69 KDM4E (0.57) KMT2AALDH1A1GAA
SCHEMBL15246477 0.69 ALDH1A1 (0.60) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL1870212 0.69 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009056693-A1 NOVEL DERIVATIVES OF N, N'- 2, 4-DIANILINOPYRIMIDINES, PREPARATION THEREOF AS MEDICAMENTS PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS IKK INHIBITORS SANOFI-AVENTIS (FR) 2009-05-07 WO disclosed